ReviewVirulence2026
Bridging environmental pollution and immune dysregulation: How microplastics disrupt gut homeostasis to promote allergic diseases.
Review in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parallel increases in microplastic (MP) pollution and allergic diseases suggest an environmental link in allergy pathogenesis. While intestinal barrier dysfunction and dysbiosis are hallmark features of allergic diseases, the mechanisms by which persistent MPs drive these processes remain unclear. This review proposes a mechanistic pathway where orally ingested MPs disrupt the intestinal barrier through physical and chemical toxicity, precipitating functional dysbiosis. Specifically, MPs suppress key short-chain fatty acid (SCFA)-producing commensals. The resulting SCFA deficit impairs the "gut-airway axis," weakening respiratory immune tolerance and increasing allergen susceptibility. We further argue for integrating gut health assessments into standardized allergy diagnostics and treatments. Despite this novel perspective, significant knowledge gaps remain regarding causality, dose-response relationships, and specific biomarkers. Addressing these challenges is critical for translating scientific findings into public health policies and clinical interventions to mitigate the rising global burden of allergic diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.